Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

21 Nov 2025 09:58

RNS Number : 5418I
Mandarin Oriental International Ltd
21 November 2025
 

ANNOUNCEMENT

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

21 November 2025 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2025.

 

· Q3 Group EBITDA improved marginally compared to last year

· Group underlying net profit was stable compared to the same quarter last year

· Three new hotel and residences management contracts announced in Q3

· Two Hotels & Residences plus one Residences scheduled to open in Q4

· Completed disposal of Munich and signed agreement for partial disposal of One Causeway Bay, advancing our asset-light strategy

· Jointly announced offer for Jardine Matheson to acquire the remaining 12% of shares in Mandarin Oriental it doesn't already own

 

Laurent Kleitman, Group Chief Executive, said:

"We have continued to execute our strategy, driving sustained growth in RevPAR and market share across key markets. We have strategically strengthened our development pipeline with the announcement of three new management contracts. We continue to elevate the brand, including through significant investments to elevate our founding flagship hotels in Hong Kong and Bangkok, demonstrating our commitment to delivering exceptional, brand-led, guest-centric experiences.

 

Our strategy remains one of asset-light growth and we were pleased to announce the partial disposal of our non-core asset One Causeway Bay at an encouraging valuation. We remain focussed on driving long-term value creation for the Group as we execute our growth strategy, progress on which was marked by the recent offer from Jardine Matheson to our minority shareholders."

 

In Q3, the Group reported higher Revenue per Available Room ('RevPAR') in all regions except for Southeast Asia compared to the prior year, with particularly robust growth in Middle East and America. The Management Business drove higher hotel management fee income from strong hotel RevPARs, and higher profitability that enables us to continue to invest against the Group's long-term growth strategy. Owned Hotels generated steady growth in EBITDA as higher profitability in Hong Kong offset the absence of earnings from Munich following the disposal of that hotel property in July. Overall, the Group's underlying profit in the quarter was similar to the same period last year.

 

The Group has made good progress in accelerating the growth of its portfolio. In the third quarter, three new hotel and residences management agreements were announced: the Group's first golf resort with branded residences in Dubai, which is uniquely positioned within the prestigious Jumeirah Golf Estates, a new luxury hotel in Seoul as our entry to the important South Korean market, and our first urban resort in the historic destination of Xian, China. The Group is now preparing for the Q4 opening of Mandarin Oriental Vienna, marking our debut in Austria at a carefully restored 117-year old former courthouse, bringing our European portfolio to 18 hotels.

 

In October, the Group announced the sale of 13 floors of our newly completed Grade A commercial building, One Causeway Bay, to Alibaba Group. At the same time, Jardine Matheson and Mandarin Oriental jointly announced an offer for Jardine Matheson to acquire the remaining 12% of shares in Mandarin Oriental it doesn't already own. If these transactions complete, Mandarin Oriental would become a private company fully owned by Jardine Matheson in 2026. Our day-to-day operations remain unchanged and our commitment to our guests, colleagues and owners remains equally unaffected.

 

As at the end of September 2025, the Group's liquidity position remains robust, with US$470 million headroom in available committed debt facilities and US$316 million of cash reserves. The Group turned to a net cash position, compared to gearing of 2% of adjusted shareholders' funds at the end of last year.

 

Mandarin Oriental Hotel Group is the award-winning owner and operator of some of the world's most luxurious hotels, resorts and residences. Having grown from its Asian roots into a global brand, the Group now operates 43 hotels, 12 residences and 26 exceptional homes in 26 countries and territories, with each property reflecting the Group's oriental heritage, local culture and unique design. Mandarin Oriental has a strong pipeline of hotels and residences under development.

 

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the equity shares (transition) category of the London Stock Exchange, with secondary listings in Bermuda and Singapore. The activities of the Group's hotels are managed from Hong Kong. Mandarin Oriental is a member of the Jardine Matheson group.

 

- end -

 

For further information, please contact:

 

Max Fleming (Director of Corporate Finance) (852) 2895 9171

 

Chris Orlikowski (Director of Global Communications) (44) 791 7280 210

William Brocklehurst (Brunswick Group Limited) (852) 5685 9881

 

This and other Group announcements can be accessed online at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKFLBLEFLEFBZ
Date   Source Headline
10th May 202311:44 amRNSDirector/PDMR Shareholding
4th May 20231:27 pmRNSAdditional Listing
4th May 20231:14 pmRNSResult of AGM
3rd May 202311:54 amRNSTransaction in Own Shares
28th Apr 202310:59 amRNSTotal Voting Rights
28th Apr 202310:50 amRNSJC&C Interim Management Statement
28th Apr 202310:23 amRNSPT Hero Supermarket Tbk Three Months 2023 Results
26th Apr 202311:30 amRNSTransaction in Own Shares
26th Apr 202310:36 amRNSDividend
24th Apr 202311:54 amRNSTransaction in Own Shares
21st Apr 202311:41 amRNSDirector/PDMR Shareholding
21st Apr 202311:10 amRNSDividend
20th Apr 202311:41 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSPT Astra 2023 First Quarter Financial Statements
18th Apr 202312:14 pmRNSTransaction in Own Shares
17th Apr 202310:26 amRNSDirectorate Change
3rd Apr 202311:24 amRNSTransaction in Own Shares
3rd Apr 202310:25 amRNSAnnual Financial Report
31st Mar 202311:15 amRNSTotal Voting Rights
30th Mar 202311:50 amRNSTransaction in Own Shares
29th Mar 202310:24 amRNSCirc re. Scrip Dividend Scheme
27th Mar 202310:34 amRNSBlock listing Interim Review
17th Mar 20239:28 amRNSPT Hero Supermarket Tbk Full Year 2022 Results
14th Mar 202310:33 amRNSTransaction in Own Shares
14th Mar 20239:26 amRNSDirector/PDMR Shareholding
2nd Mar 202312:38 pmRNSAudit Committee Membership Change
2nd Mar 202312:20 pmRNSJMH - 2022 Preliminary Results
2nd Mar 202311:20 amRNSHKLH - 2022 Preliminary Results
2nd Mar 20239:53 amRNSDairy Farm Intl - 2022 Preliminary Results
2nd Mar 20239:30 amRNSMandarin Oriental - 2022 Preliminary Results
28th Feb 202310:10 amRNSJC&C - 2022 FY Results and Dividend
27th Feb 202312:17 pmRNSPT Astra – 2022 Full Year Financial Statements
31st Jan 202310:05 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20233:17 pmRNSDirector/PDMR Shareholding
13th Jan 202310:29 amRNSTransaction in Own Shares
30th Nov 202211:15 amRNSTotal Voting Rights
21st Nov 202210:55 amRNSTransaction in Own Shares
18th Nov 202211:15 amRNSTransaction in Own Shares
16th Nov 202211:27 amRNSTransaction in Own Shares
15th Nov 202210:37 amRNSTransaction in Own Shares
10th Nov 20229:47 amRNSInterim Management Statement
10th Nov 20229:42 amRNSInterim Management Statement
10th Nov 20229:40 amRNSInterim Management Statement
10th Nov 20229:37 amRNSInterim Management Statement
9th Nov 20229:34 amRNSJC&C Interim Management Statement
8th Nov 20229:31 amRNSCorrection: Director/PDMR Shareholding
7th Nov 202210:53 amRNSDirector/PDMR Shareholding
31st Oct 202210:39 amRNSTotal Voting Rights
31st Oct 202210:37 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.